🔎 Trials Near Me

Beranda › Penyakit Arteri Perifer › Tennessee

Uji klinis Penyakit Arteri Perifer di Tennessee

14 studi untuk Penyakit Arteri Perifer mencari peserta di lokasi di Tennessee.

Kota di Tennessee

Teks studi resmi (Bahasa Inggris)

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

  • Apex Research Foundation, LLC, Jackson
  • Tennova TCMC, Knoxville
  • Vanderbilt Heart and Vascular Tullahoma, Cardiology and Vascular Associates, Tullahoma
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07318610

Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

  • The Jackson Clinic, Jackson
  • East Coast Institute for Research - Jefferson City, Jefferson City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07223593

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Southeast Renal Research Institute, Chattanooga
  • Dialysis Clinic Inc - University Nephology, Knoxville
  • Knoxville Kidney Center PLLC, Knoxville
  • dan 2 lainnya
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05485961

The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

  • Tennessee Center for Clinical Trials, Tullahoma
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT06321575

The THOR IDE Study

  • Vascular Institute of Chattanooga, Chattanooga
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Jun 2026 · NCT05916950

The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease

  • Wellmont Holston Valley Medical Center, Kingsport
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mei 2026 · NCT05811364

REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center

  • University of Tennessee Medical Center, Knoxville
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Apr 2026 · NCT07223437

SELUTION4BTK Trial

  • Vanderbilt University Medical Center, Nashville
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Apr 2026 · NCT05055297

PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

  • Vanderbilt University Medical Center, Nashville
Menerima peserta
Usia 18 hingga 95 · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT05313165

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

  • Vanderbilt University Medical Center, Nashville
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT04774159

Randomized Clinical Trial for Ewing Amputation in the VA

  • Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Menerima peserta
Semua usia · Semua jenis kelamin · Diperbarui 9 Feb 2026 · NCT05437562

Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes

  • Wellmont CVA Heart Institute, Kingsport
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 6 Feb 2026 · NCT01904851

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

  • Memphis VA Medical Center, Memphis, TN, Memphis
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Des 2025 · NCT02915198

Pounce™ Thrombectomy System Retrospective Registry

  • Vanderbilt University Medical Center, Nashville
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2025 · NCT05868161

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.